Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00753116 · ClinicalTrials.gov registry record · Phase 1

Renal Denervation in End Stage Renal Disease Patients With Refractory Hypertension

A Phase 1 study, sponsored by Medtronic Vascular.

Completed
Registry status
Phase 1
Development phase
20
Enrollment target

NCT00753116: Completed Phase 1 study, sponsored by Medtronic Vascular.

NCT00753116 is a Phase 1 study that has completed, run by Medtronic Vascular. The registered enrollment target is 20 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (67% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00753116, a Phase 1 study, has completed, sponsored by Medtronic Vascular.

COMPLETED
Registry status
Phase 1
Development phase
20 participants
Enrollment target

Study Summary

The purpose of this this study is to investigate the clinical utility of renal denervation in the treatment of ESRD patients with refractory hypertension.

Interventions

  • DEVICE Renal Denervation with a catheter-based procedure

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2008-09
Est. Completion 2009-12
Phase Phase 1
Medtronic Vascular

26 total trials

What the finished NCT00753116 record still lists

NCT00753116 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (67% lower).

The record links to 0 conditions, and to 1 intervention - of which Renal Denervation with a catheter-based procedure is the first listed.

NCT00753116 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00753116 about?

NCT00753116 is a clinical study titled "Renal Denervation in End Stage Renal Disease Patients With Refractory Hypertension". The purpose of this this study is to investigate the clinical utility of renal denervation in the treatment of ESRD patients with refractory hypertension.

What is the current status of trial NCT00753116?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2008-09. Estimated completion is 2009-12.

What interventions are being tested in trial NCT00753116?

The interventions under investigation include: Renal Denervation with a catheter-based procedure (DEVICE).

Who is sponsoring clinical trial NCT00753116?

This trial is sponsored by Medtronic Vascular, which has 26 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00753116's enrollment target sits among peer trials

20 1629th of 2000 higher than 285 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00753116, the US trial registry maintained by the National Library of Medicine. NCT00753116 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.